We are live on ! Find out more
KAM

Krensavage Asset Management Portfolio holdings

AUM $256M
1-Year Est. Return 69.63%
This Fund
S&P 500
This Quarter Est. Return
-5.73%
1 Year Est. Return
+69.63%
3 Year Est. Return
+113.28%
5 Year Est. Return
+196.5%
10 Year Est. Return
+463.27%
AUM
$308M
AUM Growth
-$61.9M
Cap. Flow
-$33.2M
Cap. Flow %
-10.76%
Top 10 Hldgs %
100%
Holding
12
New
–
Increased
3
Reduced
7
Closed
2

Top Buys

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$4.21M
2
AMGN icon
Amgen
AMGN
+$3.89M
3
ENTA icon
Enanta Pharmaceuticals
ENTA
+$318K

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$34.3M
2
MCK icon
McKesson
MCK
+$4.78M
3
BIIB icon
Biogen
BIIB
+$795K
4
GILD icon
Gilead Sciences
GILD
+$499K
5
ELAN icon
Elanco Animal Health
ELAN
+$401K

Sector Composition

Rank Sector Weight
1 Healthcare 97.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MCK icon
1
McKesson
MCK
$100B
$50.2M 16.28%
373,297
-38,358
-9% -$4.78M
UTHR icon
2
United Therapeutics
UTHR
$25.8B
$43M 13.94%
550,299
+45,000
+9% +$4.21M
BIIB icon
3
Biogen
BIIB
$30B
$41.3M 13.4%
176,556
-3,444
-2% -$795K
ENTA icon
4
Enanta Pharmaceuticals
ENTA
$366M
$40.5M 13.13%
479,576
+3,534
+0.7% +$318K
AMGN icon
5
Amgen
AMGN
$208B
$39.7M 12.88%
215,402
+21,732
+11% +$3.89M
GILD icon
6
Gilead Sciences
GILD
$162B
$37.2M 12.09%
551,237
-7,590
-1% -$499K
ELAN icon
7
Elanco Animal Health
ELAN
$13.2B
$30.1M 9.78%
891,851
-12,351
-1% -$401K
SRGA
8
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$16.6M 5.4%
130,591
-1,809
-1% -$261K
IVC
9
DELISTED
Invacare Corporation
IVC
$6.91M 2.24%
1,331,409
-18,332
-1% -$120K
AVNS
10
DELISTED
Avanos Medical
AVNS
$2.59M 0.84%
59,378
-2,679
-4% -$115K
MRK icon
11
Merck
MRK
$322B
– –
-432,624
Closed -$34.3M
STRR
12
DELISTED
Star Equity Holdings
STRR
– –
-5,903
Closed -$269K

Similar funds

CIA
Corigliano Investment Advisers Raleigh, North Carolina $256M AUM 54.89% 1-Year Est. Return
2
2Xideas Kusnacht, Switzerland $255M AUM 0.46% 1-Year Est. Return
CIM
Caldwell Investment Management Toronto, Ontario, Canada $255M AUM 36.87% 1-Year Est. Return
JFG
Juno Financial Group Richmond, Virginia $255M AUM
PIP
Palisades Investment Partners Santa Monica, California $255M AUM 50.52% 1-Year Est. Return
LRIC
Long Road Investment Counsel Kalamazoo, Michigan $255M AUM 12.85% 1-Year Est. Return
GAMC
Garner Asset Management Corp Plano, Texas $255M AUM 22.93% 1-Year Est. Return
TIA
Tiemann Investment Advisors Menlo Park, California $255M AUM 21.35% 1-Year Est. Return

Krensavage Asset Management's Q2 2019 Portfolio in Review

As of Q2 2019, Krensavage Asset Management held 12 positions worth $308M, down 17% from $370M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Krensavage Asset Management withdrew a net $33.2M in Q2 2019, closing 2 positions and reducing 7 holdings. Its most notable exit was Merck, an estimated $34.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, up from 97% a quarter earlier.

Against the trend, Krensavage Asset Management added an estimated $4.21M to United Therapeutics.

  • Krensavage Asset Management added most to United Therapeutics in Q2 2019, an estimated $4.21M increase.
  • Krensavage Asset Management's biggest Q2 2019 reduction was McKesson, cutting an estimated $4.78M.
  • Krensavage Asset Management fully exited Merck in Q2 2019, selling an estimated $34.3M.
  • Krensavage Asset Management's ten largest holdings make up 100% of its $308M portfolio in Q2 2019.
  • Krensavage Asset Management opened 0 new positions and closed 2 in Q2 2019.
  • Krensavage Asset Management's portfolio value fell 17% quarter-over-quarter to $308M.

Based on Krensavage Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.